These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2288384)

  • 1. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity.
    Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y
    Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor.
    Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B
    Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH; Young RR; Shahani BT
    Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor.
    Magnussen I; Dupont E; Prange-Hansen A; de Fine Olivarius B
    Acta Neurol Scand; 1977 Mar; 55(3):251-53. PubMed ID: 300537
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Treatment of post-anoxic intention myoclonus.
    Van Woert MH; Sethy VH
    Lancet; 1974 Jun; 1(7869):1285. PubMed ID: 4134164
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J; Richardson JC; Hornykiewicz O
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-5-hydroxytryptophan therapy in myoclonus.
    Van Woert MH; Rosenbaum D
    Adv Neurol; 1979; 26():107-15. PubMed ID: 316273
    [No Abstract]   [Full Text] [Related]  

  • 10. From the NIH: New treatment for myoclonus patients.
    JAMA; 1980 May; 243(17):1705-6. PubMed ID: 6965990
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental action and stimuli-sensitive myoclonus with acute onset. A case report.
    Avanzini G; Franceschetti S; Lombardi B; Passerini A
    Ital J Neurol Sci; 1980 Oct; 1(4):275-8. PubMed ID: 6978325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and therapeutics of posthypoxic myoclonus.
    Van Woert MH; Rosenbaum D; Chung EY
    Adv Neurol; 1986; 43():171-81. PubMed ID: 2418644
    [No Abstract]   [Full Text] [Related]  

  • 14. Posttraumatic intention myoclonus.
    Starosta-Rubinstein S; Bjork RJ; Snyder BD; Tulloch JW
    Surg Neurol; 1983 Aug; 20(2):131-2. PubMed ID: 6603671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor.
    De Léan J; Richardson JC; Rewcastle NB
    Adv Neurol; 1986; 43():215-23. PubMed ID: 2418647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine in the treatment of intention myoclonus.
    Van Woert MH; Magnussen I; Rosenbaum D; Chung E
    Clin Neuropharmacol; 1983 Mar; 6(1):49-54. PubMed ID: 6189599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD
    Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.